The Horrors That Could Lie Ahead if Vaccines Vanish Researchers at Stanford University modeled how many people could die or be disabled in 25 years if vaccines for polio, measles, rubella or diphtheria were no longer available.

The Horrors That Could Lie Ahead if Vaccines Vanish — ProPublica projects.propublica.org/childhood-va...

#publichealth #vaccines #HHS #CDC #FDA

Schreiber Foods, Inc. Issues Allergy Alert on Undeclared Tree Nuts (Almonds) in Product Schreiber Foods, Inc of Green Bay, WI is voluntarily recalling 144 Cases of Honey Almond Cream Cheese Spread, because it may contain undeclared almonds. People who have an allergy or severe sensitivity to almonds run the risk of serious or life-threatening allergic reaction if they consume this prod

FDA RECALL
Brand: Einstein Bros Bagels
Product: Honey Cream Cheese
Issue: Undeclared almonds
Date: 03/28/2026
More: www.fda.gov/safety/recalls-market-wi... #FDA #recall

An Update on Tylenol, Pregnancy, and Autism: New Science in a Political Storm The evidence has grown stronger. So has the misinformation.

The FDA said Tylenol during pregnancy may cause autism. Now the best study yet confirms: no link to autism, and the ADHD signal disappears when you look at siblings in the same family.
#Autism #Pregnancy #Tylenol #FDA #ChildHealth #PublicHealth #Pediatrics #Misinformation

Food Safety in America Just Hit a New Low The FDA has linked an E. coli outbreak to raw-cheddar cheese. The company that sells it refuses to agree to a recall.

America’s Raw-Cheddar Chaos
#Trump #FDA

#RepostEverywhere
#Medication #Generics
#FDA

Original post on ai6yr.org

FDA RECALL
Brand: Vital Nutrient
Product: Aller-C Dietary Supplement
Issue: Undeclared egg, hazelnut and soy
Date: 03/27/2026
More […]

FDA approves Viagra | March 27, 1998 | HISTORY On March 27, 1998, the Food and Drug Administration (FDA) approves use of the drug Viagra, an oral medication that tr...

www.history.com/this-day-in-...

Guess the FDA rose to the occasion.

#FDA #viagra #history

Viagra remains one of the most widely recognized pharmaceutical products, helping men all around the world think they still got it.

Follow the page for more daily history!

#Viagra #FDA #MedicalHistory #Pfizer #Healthcare #Pharmaceuticals

FDA flags misleading claims for cancer drug by biotech billionaire Patrick Soon-Shiong - WTOP News WASHINGTON (AP) — Federal health officials posted a warning Tuesday about misleading statements made by biotech billionaire Dr. Patrick Soon-Shiong, who recently told podcast listeners that his…

The FDA warned biotech company ImmunityBio over misleading claims about its cancer drug.

#FDA #Cancer #HealthPolicy #FalseAds
wtop.com/national/202...

FDA’dan kritik uyarı: Evinde varsa hemen kontrol et! Çocuk şurubunda toplatma kararı FDA, çocuklar için kullanılan belirli parti ibuprofen şuruplarında yabancı maddeler tespit edilmesi üzerine geri çağırma kararı aldı; ailelere lot numarası kontrolü uyarısı yapıldı.

FDA’dan kritik uyarı: Evinde varsa hemen kontrol et! Çocuk şurubunda toplatma kararı
FDA, çocuklar için kullanılan belirli parti ibuprofen şuruplarında yabancı maddeler tespit edilmesi üzerine geri çağırma kararı aldı; ailelere lot numarası kontrolü uyarısı yapıldı.

#FDA #şurup #abd #sağlık #news

In 2023, the FDA issued draft guidance on clinical investigations for psychedelic drugs. The document says it is meant to give sponsors general considerations for developing psychedelic drugs for medical conditions, including trial conduct, data collection, and subject safety.

#Psychedelics #FDA

FDA Supplement Regulation Debate Intensifies as Industry Pushes Peptide Approval The debate over FDA supplement regulation is intensifying as U.S. health authorities weigh whether to broaden the definition of permissible

U.S. regulators face mounting pressure to expand supplement rules as peptides gain popularity, raising safety, oversight, and public health concerns globally.

#HealthPolicy #FDA #PublicHealth #Peptides #GlobalHealth

Pharmalittle: We're reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more Novo Nordisk appointed Poul Weihrauch, CEO of the Mars candy company, as board observer as it tries to boost its consumer focus

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more news.. statnews.com/pharmalot/20... #pharma #FDA #genetherapy #obesity #depression #hepatitisC

Touchdown for Rocket as its first gene therapy gets US okay Rocket Pharma has won FDA approval for the first gene therapy for LAD-I, a devastating genetic disorder causing severe vulnerability to infections.

At its second attempt, #RocketPharma has won #FDA approval for its #genetherapy for severe leukocyte adhesion deficiency type I (LAD-I), a rare and life-threatening #immunedisorder that leaves patients vulnerable to life-threatening #infections.

Medtronic's Stealth AXiS™ Surgical System: A Game-Changer for Cranial and ENT Procedures Medtronic has received FDA clearance for the Stealth AXiS™ Surgical System, revolutionizing cranial and ENT procedures with advanced navigation and robotics.

Medtronic's Stealth AXiS™ Surgical System: A Game-Changer for Cranial and ENT Procedures #USA #FDA #Medtronic #Galway #Stealth_AXiS™

🚨 Latest #FDA Update!

🔷 The FDA has approved PD-L1 IHC 22C3 pharmDx as a companion diagnostic for patients with esophageal and gastroesophageal junction (GEJ) carcinoma, enabling identification of patients with PD-L1 CPS ≥1 who may benefit from pembrolizumab.

🚨 Latest #FDA Update!

🔷 The FDA has approved Lifyorli™ (Relacorilant) in combination with Nab-paclitaxel for patients with platinum-resistant ovarian cancer, introducing a novel treatment option in a difficult-to-treat setting.

Regulatory Science Expert Urges FDA to Finalize Long-Delayed Policies Addressing Conflicts of Interest Dr. Sarfaraz K. Niazi has filed a citizen petition with the FDA, urging action on delayed conflict-of-interest guidelines, highlighting transparency issues that affect advisory committees.

Regulatory Science Expert Urges FDA to Finalize Long-Delayed Policies Addressing Conflicts of Interest #United_States #Chicago #FDA #Sarfaraz_Niazi #conflict_of_interest

Original post on ai6yr.org

FDA RECALL
Brand: Falcon Trading Company
Product: Black Beans Organic , Chili Bean Blend Organic, Sunset Soup Mix Organic
Issue: Product contains pesticide residue
Date: 03/26/2026
More […]

Gear Isle Issues Voluntary Nationwide Recall of Chocolate Product Due to Undeclared Sildenafil and Tadalafil FOR IMMEDIATE RELEASE – March 19, 2026– West Sacramento, CA, Gear Isle is voluntarily recalling the following products to the consumer level. The products have been found to contain undeclared active pharmaceutical ingredients, sildenafil and tadalafil.

FDA RECALL
Brand: Gold Lion, ilum
Product: Chocolate
Issue: Product contains sildenafil and tadalafil
Date: 03/26/2026
More: www.fda.gov/safety/recalls-market-wi... #FDA #recall

FDA Confirms Widespread PFAS in Cosmetics, Admits Safety Unknown for Most FDA confirms widespread PFAS in cosmetics, but safety data for most chemicals remains unknown. Learn more about the risks and regulatory actions.

📍FDA Confirms Widespread PFAS in Cosmetics, Admits Safety Unknown for Most.

FDA confirms widespread PFAS in cosmetics, but safety data for most chemicals remains unknown. Learn more about the risks and regulatory actions.

#Health #Science #PFAS #Cosmetics #FDA
factide.com/fda-confirms...

Hagens Berman Expands Investigation into uniQure Amid FDA Controversies and Allegations of Data Misrepresentation Hagens Berman's ongoing investigation into uniQure N.V. follows serious accusations from the FDA regarding potential data misrepresentation, impacting investors significantly.

Hagens Berman Expands Investigation into uniQure Amid FDA Controversies and Allegations of Data Misrepresentation #USA #San_Francisco #FDA #Securities_Class_Action #uniQure

Soaring FDA Costs and Increasing Drug Rejections Highlight Regulatory Challenges A new report reveals escalating costs and rising rejection rates in the FDA's drug approval process, raising concerns about patient access to medications.

Soaring FDA Costs and Increasing Drug Rejections Highlight Regulatory Challenges #USA #Washington #FDA #TPA #Drug_Approvals

FDA opens door to feedback on ‘unclear’ national priority voucher pathway - Pharmaceutical Technology A total of 18 vouchers have been issued via the framework despite a lack of clarity on the awarding process.

FDA convenes a public hearing following mixed reviews for its Commissioner’s National Priority Voucher (CNPV) pilot programme

www.pharmaceutical-technology.com/news/fda-ope...

#pharma #fda

I really wish #Congress would push the #FDA to allow more insurance coverage for GLP-1’s. The #Science is showing they have many more applications than weight loss! Addiction therapy, inflammation/NASH, Insulin Resistance/Metabolic Dz, & reduces cardiac dz caused by the above!

🚨 Latest #FDA Update!

🔷 TRIANA Biomedicines’ TRI-611 has received U.S. FDA Fast Track designation for the treatment of ALK-positive non-small cell lung cancer. The designation highlights the therapy’s potential to address an unmet need in targeted lung cancer treatment.

Pomerantz Law Firm Investigates Possible Securities Fraud by PepGen Inc. Pomerantz LLP is looking into potential securities fraud involving PepGen Inc. as it faces a FDA clinical hold impacting its drug trials, affecting stock prices significantly.

Pomerantz Law Firm Investigates Possible Securities Fraud by PepGen Inc. #USA #New_York #FDA #Pomerantz_Law_Firm #PepGen_Inc.

Pharmalittle: We're reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more The FDA approved a Denali medicine for Hunter syndrome, a notable decision as the agency has recently taken tougher stances on rare disease drugs

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more news.. statnews.com/pharmalot/20... #pharma #patents #obesity #340B #abortion #HIV #FDA #raredisease #Florida #NovoNordisk

Corcept gets FDA OK for first-in-class ovarian cancer drug Corcept shares surge on FDA approval of Lifyorli, a first-in-class selective glucocorticoid receptor antagonist for ovarian cancer.

#Corcept shares surge on #FDA approval of Lifyorli, a first-in-class selective glucocorticoid receptor antagonist for ovarian cancer.

**Commercial FREE* content. We need to know:

#FDA free from regulation.
www.youtube.com/watch?v=82co...